Trial Profile
Retrospective chart review investigating the long term efficacy and tolerability of deferasirox in patients with transfusion-dependent beta thalassemia in Taiwanese patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Feb 2016
Price :
$35
*
At a glance
- Drugs Deferasirox (Primary)
- Indications Beta-thalassaemia
- Focus Adverse reactions; Therapeutic Use
- 10 Feb 2016 New trial record